×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
ShiraTronics Completes Enrollment in the RELIEV-CM2 Pivotal Trial for Implantable Extracranial Neuromodulation Systems (IENs) to Treat Chronic Migraine
The Newly Expanded Hepatus-Series Ultrasound Systems Lead the Evolution of Gastroenterology Imaging by Mindray
SOUND REACH™ Swift Receives CE Mark Approval from Reach Surgical
Waters Unveils the Cyclic IMS P20 MS, Setting a New Benchmark in Structural and Spatial Omics
Waters Launched Xevo MRT P10 MS to Accelerate Multiomics Research with Enhanced HRMS Performance
Qualia Launched Clinically Tested Qualia Vitamin C+ to Enhance Vitamin C Absorption and Utilization
SCIEX Launch the novus V55 System, Featuring SCIEX OS 5.0 Software and AI-Enabled Tools
Quotient Sciences advances AI-designed drug product into clinical development.
Abbott secures the CE Mark for the world’s first dual glucose and ketone sensing technology for people with diabetes
New Case Study Finds Accelerated TMS Reduces Teen Depression and Anxiety
DoctorDerm unveils a rebrand and expands its platform with new prescription skin and lash treatments.
Rain Eyecare, the first dedicated dry eye telehealth brand, has launched FeelRain.com
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era in U.S. Prenatal Care
By
Pulsenmore Ltd.
Pulsenmore Ltd.
03 Nov 2025
CathWorks completes enrollment for the ALL-RISE trial, advancing coronary artery disease treatment
Luxor® Workspaces Debuts a Research-Driven Collection of Medical Workstations with a Focus on Healthcare
Using social determinants of health, an AI model predicts readmissions of pregnant women with lupus in an HSS study
FDA Approves Myhibbin™ by Azurity Pharmaceuticals, Inc., a Mycophenolate Mofetil Oral Suspension
Nicklaus Children’s Appoints New Board Chairs Across Its Health System, Hospital, and Foundation
Featured Press Releases
ShiraTronics Completes Enrollment in the RELIEV-CM2 Pivotal Trial for Implantable Extracranial Neuromodulation Systems (IENs) to Treat Chronic Migraine
The Newly Expanded Hepatus-Series Ultrasound Systems Lead the Evolution of Gastroenterology Imaging by Mindray
03 Jun 2026
Mindray, a global leader in healthcare innovation across perioperative, medical imaging, and
...
SOUND REACH™ Swift Receives CE Mark Approval from Reach Surgical
Waters Unveils the Cyclic IMS P20 MS, Setting a New Benchmark in Structural and Spatial Omics
Waters Launched Xevo MRT P10 MS to Accelerate Multiomics Research with Enhanced HRMS Performance
Qualia Launched Clinically Tested Qualia Vitamin C+ to Enhance Vitamin C Absorption and Utilization
ShiraTronics Completes Enrollment in the RELIEV-CM2 Pivotal Trial for Implantable Extracranial Neuromodulation Systems (IENs) to Treat Chronic Migraine
By
ShiraTronics, Inc.
ShiraTronics, Inc.
03 Jun 2026
The Newly Expanded Hepatus-Series Ultrasound Systems Lead the Evolution of Gastroenterology Imaging by Mindray
By
Mindray North America
Mindray North America
03 Jun 2026
SOUND REACH™ Swift Receives CE Mark Approval from Reach Surgical
By
Genesis MedTech Group
Genesis MedTech Group
03 Jun 2026
Waters Unveils the Cyclic IMS P20 MS, Setting a New Benchmark in Structural and Spatial Omics
By
Waters Corporation
Waters Corporation
02 Jun 2026
Waters Launched Xevo MRT P10 MS to Accelerate Multiomics Research with Enhanced HRMS Performance
By
Waters Corporation
Waters Corporation
02 Jun 2026
Qualia Launched Clinically Tested Qualia Vitamin C+ to Enhance Vitamin C Absorption and Utilization
By
Qualia Life Sciences
Qualia Life Sciences
01 Jun 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
BioActive Vitamin B6™—the First Tri-Cofactor B6 System with P-5-P, Riboflavin, and Albion® Magnesium—is Launched by Triquetra Health
By
Triquetra Health LLC
Apr 29
With FDA-Cleared Accelerated Deep TMS Protocol, Serenity Mental Health Centers Expands Access in Colorado Springs
By
Serenity Mental Health Centers
Nov 01
Algiax Pharmaceuticals expands AP-325 study in chronic neuropathic pain, adds 12 sites in Belgium and France
By
Algiax Pharmaceuticals GmbH
Apr 11
June
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Healthcare Era’s monthly newsletter,
Healthcare Leaders Digest
®, to receive timely updates from across the healthcare industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand